Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_assertion type Assertion NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_head.
- NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_provenance.
- NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_assertion evidence source_evidence_literature NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_provenance.
- NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_assertion SIO_000772 17456787 NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_provenance.
- NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_assertion wasDerivedFrom befree-20140225 NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_provenance.
- NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_assertion wasGeneratedBy ECO_0000203 NP261974.RAcNqOvb9Qe5nBV6KRAQ3YLZ5QfmwbsOYAap7cqYvSBlc130_provenance.